Ralph DeFronzo
Ralph DeFronzo
UTHSCSA
Verified email at uthscsa.edu
TitleCited byYear
Glucose clamp technique: a method for quantifying insulin secretion and resistance
RA DeFronzo, JD Tobin, R Andres
American Journal of Physiology-Gastrointestinal and Liver Physiology 237 (3 …, 1979
81481979
Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
RA DeFronzo, E Ferrannini
Diabetes care 14 (3), 173-194, 1991
59621991
Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.
M Matsuda, RA DeFronzo
Diabetes care 22 (9), 1462-1470, 1999
44071999
Insulin sensitivity indices obtained from oral glucose tolerance test: Comparison with the euglycemic insulin clamp
M Matsuda, RA Defronzo
Diabetes 48, A79-A79, 1999
44071999
The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM
RA DeFronzo
Diabetes 37 (6), 667-687, 1988
31201988
Pathogenesis of NIDDM: a balanced overview
RA DeFronzo, RC Bonadonna, E Ferrannini
Diabetes care 15 (3), 318-368, 1992
26581992
Report of the expert committee on the diagnosis and classification of diabetes mellitus
JR Gavin, K Alberti, MB Davidson, RA DeFronzo, A Drash, SG Gabbe, ...
Diabetes Care 23, S4-S19, 2000
2319*2000
International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes
DM Nathan, DM Nathan, B Balkau, E Bonora, K Borch-Johnsen, JB Buse, ...
Diabetes Care 32 (7), 1327-1334, 2009
23012009
Report of the expert committee on the diagnosis and classification of diabetes mellitus
JR Gavin III, K Alberti, MB Davidson, RA DeFronzo
Diabetes Care 24, S5, 2001
2258*2001
From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus
RA DeFronzo
Diabetes 58 (4), 773-795, 2009
21782009
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1
ME Patti, AJ Butte, S Crunkhorn, K Cusi, R Berria, S Kashyap, Y Miyazaki, ...
Proceedings of the National Academy of Sciences 100 (14), 8466-8471, 2003
18962003
Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes
R DeFronzo, R Ratner, J Han, D Kim, M Fineman, A Baron
Diabetologia 47, A280-A280, 2004
18242004
Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes
RA DeFronzo, RE Ratner, J Han, DD Kim, MS Fineman, AD Baron
Diabetes care 28 (5), 1092-1100, 2005
18072005
The effect of insulin on the disposal of intravenous glucose: results from indirect calorimetry and hepatic and femoral venous catheterization
RA DeFronzo, E Jacot, E Jequier, E Maeder, J Wahren, JP Felber
Diabetes 30 (12), 1000-1007, 1981
17121981
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
R Belfort, SA Harrison, K Brown, C Darland, J Finch, J Hardies, B Balas, ...
New England Journal of Medicine 355 (22), 2297-2307, 2006
15542006
Pharmacologic therapy for type 2 diabetes mellitus
RA DeFronzo
Annals of internal medicine 131 (4), 281-303, 1999
15101999
Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus
RA DeFronzo, AM Goodman
New England Journal of Medicine 333 (9), 541-549, 1995
14301995
Impaired fasting glucose and impaired glucose tolerance implications for care
DM Nathan, MB Davidson, RA Defronzo, RJ Heine, RR Henry, R Pratley, ...
Diabetes care 30 (3), 753-759, 2007
13632007
Consensus Statement Impaired fasting glucose and impaired glucose tolerance: implications for care
DM Nathan, M Davidson, RA DeFronzo, RJ Heine, RR Henry, R Pratley, ...
DIABETES CARE-ALEXANDRIA VA- 30 (3), 753, 2007
1363*2007
Report of the expert committee on the diagnosis and classification of diabetes mellitus
JR Gavin III, K Alberti, MB Davidson, RA DeFronzo
Diabetes care 20 (7), 1183, 1997
13341997
The system can't perform the operation now. Try again later.
Articles 1–20